SCHEMBL484776

SCHEMBL484776

O=C(O)c1ccc2c(c1)C(N1Cc3cccc(Cl)c3C1=O)CCC2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
CTSD P07339 1/20 0.39
HTR2C P28335 2/20 0.39
HTR2A P28223 1/20 0.39
HTR2B P41595 1/20 0.39
ALDH1A1 P00352 2/20 0.39
CRBN Q96SW2 2/20 0.38
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
TAS1R2 Q8TE23 2/20 0.38
PARP1 P09874 2/20 0.37
POLB P06746 1/20 0.37
HTT P42858 1/20 0.37
ESR2 Q92731 1/20 0.37
KDM4E B2RXH2 1/20 0.36
DRD3 P35462 1/20 0.36
AKR1C3 P42330 2/20 0.36
AKR1C2 P52895 2/20 0.36
AKR1C1 Q04828 1/20 0.36
CYP1A2 P05177 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2822029 1.00 MAPT (0.41) MAPTCTSDHTR2CHTR2AHTR2B
SCHEMBL785475 1.00 MAPT (0.41) MAPTCTSDHTR2CHTR2AHTR2B
SCHEMBL785044 0.94 CRBN (0.42) MAPTHTR2CHTR2AHTR2BALDH1A1
SCHEMBL484302 0.94 CRBN (0.42) MAPTHTR2CHTR2AHTR2BALDH1A1
SCHEMBL803745 0.88 HSP90AA1 (0.41) MAPTCTSDHTR2CHTR2AHTR2B
SCHEMBL2819048 0.88 HSP90AA1 (0.41) MAPTCTSDHTR2CHTR2AHTR2B
SCHEMBL2819046 0.88 HSP90AA1 (0.41) MAPTCTSDHTR2CHTR2AHTR2B
SCHEMBL785795 0.86 CRBN (0.42) MAPTHTR2CHTR2AHTR2BALDH1A1
SCHEMBL785723 0.86 CRBN (0.42) MAPTHTR2CHTR2AHTR2BALDH1A1
SCHEMBL2816152 0.86 CRBN (0.42) MAPTHTR2CHTR2AHTR2BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-20130231327-A1 Substituted Spiro-Amide Compounds GRUENENTHAL GMBH (DE) 2013-09-05 US disclosed
US-8455475-B2 Substituted spiro-amide compounds GRUENENTHAL GMBH (DE) 2013-06-04 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
EP-2411381-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-02-01 EP disclosed
US-20100249095-A1 Substituted Spiro-amide Compounds GRUENENTHAL GMBH (DE) 2010-09-30 US disclosed
WO-2010108651-A1 SUBSTITUTED SPIRO-AMIDE COMPOUNDS Grünenthal GmbH (DE) 2010-09-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130231327-A1 Substituted Spiro-Amide Compounds BDKRB1, BDKRB2, REN MAPT 4634/4885CTSD 1598/4885HTR2C 1903/4885
US-20100249095-A1 Substituted Spiro-amide Compounds BDKRB1, BDKRB2, REN MAPT 4634/4885CTSD 1598/4885HTR2C 1903/4885
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 MAPT 3149/4885CTSD 310/4885HTR2C 549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.